Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...

After years of search and experimentation, this teacher finally hit on a room layout that allowed for efficient shifting between whole class, small group, and independent work.

The changes, which are in the early discussion stages, could be a major shift in how DeKalb educates its students. The ...